Exercise intolerance in heart failure with preserved ejection fraction: Shifting Focus from the heart to peripheral skeletal muscle

Journal of the American College of Cardiology

Volumn 60, Issue 2, 2012, Pages 129-131

  Maurer, Mathew S ^a   Schulze, P Christian ^a  

^a New York Presbyterian Morgan Stanley Children's Hospital   (United States)

Author keywords

elderly; exercise; heart failure; peripheral; preserved ejection fraction

Indexed keywords

HEMOGLOBIN;

DISABILITY; EXERCISE INTOLERANCE; EXERCISE TEST; EXERCISE TOLERANCE; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART OUTPUT; HEART REHABILITATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INFLAMMATION; LUNG FUNCTION; NOTE; OUTCOME ASSESSMENT; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; SELF REPORT; VASODILATATION;

EID: 84863447528     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.04.012     Document Type: Editorial

References (29)

1. J.R. Wilson, S. Hanamanthu, D.B. Chomsky, S.F. Davis Relationship between exertional symptoms and functional capacity in patients with heart failure J Am Coll Cardiol 33 1999 1943 1947
2. D.M. Mancini, G. Walter, N. Reichek Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure Circulation 85 1992 1364 1373
3. M. Haykowsky, P.H. Brubaker, K.P. Stewart, T.M. Morgan, J. Eggebeen, D.W. Kitzman Effect of endurance training on the determinants of peak exercise oxygen consumption in elderly patients with stable compensated heart failure and preserved ejection fraction J Am Coll Cardiol 60 2012 120 128
4. T. Bhuiyan, M.S. Maurer Heart failure with preserved ejection fraction: persistent diagnosis, therapeutic enigma Curr Cardiovasc Risk Rep 5 2011 440 449
5. M.J. Haykowsky, P.H. Brubaker, J.M. John, K.P. Stewart, T.M. Morgan, D.W. Kitzman Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction J Am Coll Cardiol 58 2011 265 274
6. M.S. Maurer, S.L. Hummel Heart failure with a preserved ejection fraction: what is in a name? J Am Coll Cardiol 58 2011 275 277
7. B.D. Duscha, P.C. Schulze, J.L. Robbins, D.E. Forman Implications of chronic heart failure on peripheral vasculature and skeletal muscle before and after exercise training Heart Fail Rev 13 2008 21 37
8. H. Drexler, U. Riede, T. Munzel, H. Konig, E. Funke, H. Just Alterations of skeletal muscle in chronic heart failure Circulation 85 1992 1751 1759
9. D.M. Mancini, E. Coyle, A. Coggan Contribution of intrinsic skeletal muscle changes to 31P NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure Circulation 80 1989 1338 1346
10. C.M. O'Connor, D.J. Whellan, K.L. Lee Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial JAMA 301 2009 1439 1450
11. J.A. Franciosa, M. Park, T.B. Levine Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure Am J Cardiol 47 1981 33 39
12. D.G. Peters, H.L. Mitchell, S.A. McCune, S. Park, J.H. Williams, S.C. Kandarian Skeletal muscle sarcoplasmic reticulum Ca(2+)-ATPase gene expression in congestive heart failure Circ Res 81 1997 703 710
13. A. Linke, V. Adams, P.C. Schulze Antioxidative effects of exercise training in patients with chronic heart failure: increase in radical scavenger enzyme activity in skeletal muscle Circulation 111 2005 1763 1770
14. B.D. Duscha, W.E. Kraus, S.J. Keteyian Capillary density of skeletal muscle: a contributing mechanism for exercise intolerance in class II-III chronic heart failure independent of other peripheral alterations J Am Coll Cardiol 33 1999 1956 1963
15. R. Hambrecht, P.C. Schulze, S. Gielen Reduction of insulin-like growth factor-I expression in the skeletal muscle of noncachectic patients with chronic heart failure J Am Coll Cardiol 39 2002 1175 1181
16. S.D. Anker, M. Volterrani, C.D. Pflaum Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone J Am Coll Cardiol 38 2001 443 452
17. V. Adams, B. Nehrhoff, U. Spate Induction of iNOS expression in skeletal muscle by IL-1beta and NFkappaB activation: an in vitro and in vivo study Cardiovasc Res 54 2002 95 104
18. M. Cesari, M. Pahor Target population for clinical trials on sarcopenia J Nutr Health Aging 12 2008 470 478
19. L.P. Fried, C.M. Tangen, J. Walston Frailty in older adults: evidence for a phenotype J Gerontol A Biol Sci Med Sci 56 2001 M146 M156
20. J. Afilalo, S. Karunananthan, M.J. Eisenberg, K.P. Alexander, H. Bergman Role of frailty in patients with cardiovascular disease Am J Cardiol 103 2009 1616 1621
21. R. Roubenoff, H. Parise, H.A. Payette Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study Am J Med 115 2003 429 435
22. J. Afilalo, M.J. Eisenberg, J.F. Morin Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery J Am Coll Cardiol 56 2010 1668 1676
23. P. Green, A.E. Woglom, P. Genereux Gait speed and dependence in activities of daily living in older adults with severe aortic stenosis Clin Cardiol 35 2012 307 314
24. H.N. Sabbah, H. Shimoyama, V.G. Sharov Effects of ACE inhibition and beta-blockade on skeletal muscle fiber types in dogs with moderate heart failure Am J Physiol 270 1996 H115 H120
25. R. Hambrecht, E. Fiehn, J. Niebauer Effects of physical exercise on oxidative enzyme activity and fiber type distribution in skeletal muscle of patients with chronic failure Circulation 92 1995 1578
26. R. Hambrecht, P.C. Schulze, S. Gielen Effects of exercise training on insulin-like growth factor-I expression in the skeletal muscle of non-cachectic patients with chronic heart failure Eur J Cardiovasc Prev Rehabil 12 2005 401 406
27. R. Hambrecht, E. Fiehn, C. Weigl Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure Circulation 98 1998 2709 2715
28. N.P. Gullett, G. Hebbar, T.R. Ziegler Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting Am J Clin Nutr 91 Suppl 2010 1143 1147
29. A.L. Caforio, B. Rossi, R. Risaliti Type 1 fiber abnormalities in skeletal muscle of patients with hypertrophic and dilated cardiomyopathy: evidence of subclinical myogenic myopathy J Am Coll Cardiol 14 1989 1464 1473